These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 13656845)

  • 1. [Notes on a case of primary hepatic steatosis with glycogenosic symptoms].
    MARTONI L; BABINI B
    Minerva Pediatr; 1959 Mar; 11(13):366-7. PubMed ID: 13656845
    [No Abstract]   [Full Text] [Related]  

  • 2. [Notes on a case of primary hepatic steatosis with symptoms of glycogenosis].
    MARTONI L; BABINI B
    Pediatrie; 1959; 14(3):313-5. PubMed ID: 13667361
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatic steatosis in children.
    Colon AR
    Am J Gastroenterol; 1977; 68(3):260-9. PubMed ID: 413433
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic steatosis in Dunnigan-type familial partial lipodystrophy.
    Lüdtke A; Genschel J; Brabant G; Bauditz J; Taupitz M; Koch M; Wermke W; Worman HJ; Schmidt HH
    Am J Gastroenterol; 2005 Oct; 100(10):2218-24. PubMed ID: 16181372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of hepatic steatosis in kwashiorkor treated by hyperprotein diet; simple & electron microscopic study].
    CAMAIN R; ROUILLER C; DUPIN H
    Ann Anat Pathol (Paris); 1959; 4(2):220-41. PubMed ID: 13650240
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.
    Bradbury MW
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G194-8. PubMed ID: 16407588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
    Choi SS; Diehl AM
    Curr Opin Lipidol; 2008 Jun; 19(3):295-300. PubMed ID: 18460922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines.
    Belingheri M; Ghio L; Sala A; Menni F; Trespidi L; Ferraresso M; Berardinelli L; Rossi G; Edefonti A; Parini R
    Liver Transpl; 2007 May; 13(5):762-4. PubMed ID: 17457869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
    Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
    Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fatty liver caused by overloading].
    DARNIS F
    Rev Prat; 1963 Jan; 13():77-92. PubMed ID: 14025142
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C and nonalcoholic fatty liver disease.
    Ramesh S; Sanyal AJ
    Semin Liver Dis; 2004 Nov; 24(4):399-413. PubMed ID: 15605308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the lipogenic pathway in the development of hepatic steatosis.
    Postic C; Girard J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):643-8. PubMed ID: 19195625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of histological features in non-alcoholic fatty liver disease.
    Vasdev N; Kakati AG; Saigal S; Nayak NC
    Natl Med J India; 2007; 20(6):282-7. PubMed ID: 18335793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
    Araya J; Rodrigo R; Videla LA; Thielemann L; Orellana M; Pettinelli P; Poniachik J
    Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of hepatic microcirculation in fatty liver.
    Ijaz S; Yang W; Winslet MC; Seifalian AM
    Microcirculation; 2003 Dec; 10(6):447-56. PubMed ID: 14745457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual presentation of Wilson's disease in childhood: nodular fatty infiltration in liver.
    Kuloğlu Z; Kansu A; Demirçeken F; Erden E; Fitoz S; Girgin N
    Turk J Pediatr; 2008; 50(2):167-70. PubMed ID: 18664082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
    Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
    Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease: emerging mechanisms and consequences.
    Turkish AR
    Curr Opin Clin Nutr Metab Care; 2008 Mar; 11(2):128-33. PubMed ID: 18301087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.